Stocktoria

NutriBand Inc. NTRB

Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2017-06-20 · LEI

NutriBand Inc. financials (annual)

Revenue
$245285 $119364 $943702 $1.4M $2.1M $2.1M $2.1M $2.0M 2017201820192020202120222023202420252026
Net income
-$151260 -$2.7M -$3.3M -$2.7M -$2.9M -$6.2M -$4.5M -$5.5M -$10.5M -$8.2M 2017201820192020202120222023202420252026
Free cash flow
-$1.1M -$2.9M -$3.1M -$3.6M -$4.7M -$5.1M 2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$2.0M$2.1M$2.1M$2.1M$1.4M$943,702$119,364$245,285
Gross profit$566,308$743,317$862,105$750,404$554,310$316,234
R&D expense$1.9M$3.1M$2.0M$982,227$411,383
SG&A expense$7.0M$4.3M$3.8M$3.9M$4.0M$2.9M$1.8M$3.3M$171,946$151,260
Operating income-$8.3M-$10.3M-$4.9M-$4.5M-$6.1M-$2.6M-$2.0M-$3.3M-$2.7M-$151,260
Interest expense$75,815$8,289$118,421$280,686$73,413
Net income-$8.2M-$10.5M-$5.5M-$4.5M-$6.2M-$2.9M-$2.7M-$3.3M-$2.7M-$151,260
EPS (diluted)$-2.58$-0.99$-0.69$-0.53$-0.80
Operating cash flow-$5.1M-$4.6M-$3.5M-$3.0M-$2.8M-$297,055-$894,470-$1.1M-$92,858-$147,923
Free cash flow-$5.1M-$4.7M-$3.6M-$3.1M-$2.9M-$1.1M
Cash & equivalents$4.6M$4.3M$492,942$2.0M$4.9M$151,993$10,181$474,653$27,124
Inventory$117,987$212,041$168,605$229,335$131,648$52,848$4,133$8,048
Total assets$7.5M$7.5M$7.5M$9.5M$12.7M$9.9M$2.2M$2.8M$164,899$37,727
Total liabilities$868,447$1.0M$1.1M$883,387$880,375$2.8M$2.0M$14,618
Shareholders' equity$6.7M$6.4M$6.4M$8.6M$11.9M$7.1M$175,433$2.4M$121,508$23,109

Growth · year-over-year · Revenue CAGR 35.3%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth-4.8%+2.6%+0.3%+46.2%+50.7%+690.6%-51.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.